Insight, Top 50 Pharma

Warner Chilcott: Company Profile

Posted on 02 February 2012

Return to top 50 pharma list

Summary

Website: Warner

Headquarters: Dublin, Ireland

Ticker Symbol: WCRX (Nasdaq Stock Exchange) G3LA (Frankfurt Stock Exchange) G3L (Frankfurt Stock Exchange)

SEC Link: Warner

Subsidiaries:

Galen Holdings

Top 50 Pharma ranking*: 39

*Ranking based on reported global pharma sales for year ending December 2010.

Sales revenue (USD billions) [% change from 2009]: $2.9 [111.0%]

R&D spend (USD millions): $147

Top-selling drugs (USD billions): Actone [1.0]

Partnering activity

View partnering activity: 2011,2010,2009,2008,2007,2006,2005

Full details on each deal can be found at CurrentAgreements (subscription required)

M&A activity

View M&A activity: 2011,2010,2009,2008,2007,2006,2005

Full details on each deal can be found at CurrentAgreements (subscription required)

Available reports from Current Partnering:

Partnering Agreements with Warner Chilcott

Partnering Agreements with Big Pharma, 3rd edition

Search all reports

Available resources providing deal coverage for Warner Chilcott:

Current Agreements (subscription required)

Request a complimentary trial

Search Current Partnering for mention of Warner Chilcott:

Search now

return to top 50 pharma list

Leave a Reply

*